Anti-tumour activity of T cells expressing chimeric receptors which incorporate both primary and costimulatory signalling sequences

被引：0
|
作者：
Lawson, ADG [1 ]
Finney, HM [1 ]
Moser, RN [1 ]
Bergin, M [1 ]
Suitters, A [1 ]
Antoniw, P [1 ]
Eddleston, A [1 ]
Weir, ANC [1 ]
机构：
[1] Celltech R&D Ltd, Slough SL1 4EN, Berks, England
来源：
CANCER GENE THERAPY | 2001年 / 8卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
PD46
引用
收藏
页码：922 / 922
页数：1
相关论文
共 50 条
  • [11] Targeting of T cells to CEA-expressing tumor cells by chimeric immune receptors with a highly specific single-chain anti-CEA activity
    Arakawa, F
    Shibaguchi, H
    Xu, ZW
    Kuroki, M
    ANTICANCER RESEARCH, 2002, 22 (6C) : 4285 - 4289
  • [12] Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells
    Majid Momeny
    Zahra Sabourinejad
    Ghazaleh Zarrinrad
    Farima Moghaddaskho
    Haniyeh Eyvani
    Hassan Yousefi
    Shahab Mirshahvaladi
    Ensieh M. Poursani
    Farinaz Barghi
    Arash Poursheikhani
    Leila Dardaei
    Davood Bashash
    Mahmoud Ghazi-Khansari
    Seyyed M. Tavangar
    Ahmad R. Dehpour
    Marjan Yaghmaie
    Kamran Alimoghaddam
    Ardeshir Ghavamzadeh
    Seyed H. Ghaffari
    Scientific Reports, 7
  • [13] Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
    James N. Kochenderfer
    Steven A. Rosenberg
    Nature Reviews Clinical Oncology, 2013, 10 : 267 - 276
  • [14] Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
    Kochenderfer, James N.
    Rosenberg, Steven A.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (05) : 267 - 276
  • [15] T Cells Expressing Anti B-Cell Maturation Antigen Chimeric Antigen Receptors for Plasma Cell Malignancies
    Li, Chunrui
    Wang, Qiuxiang
    Zhu, Hui
    Mao, Xia
    Wang, Ying
    Zhang, Yicheng
    Zhou, Jianfeng
    BLOOD, 2018, 132
  • [16] Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells
    Momeny, Majid
    Sabourinejad, Zahra
    Zarrinrad, Ghazaleh
    Moghaddaskho, Farima
    Eyvani, Haniyeh
    Yousefi, Hassan
    Mirshahvaladi, Shahab
    Poursani, Ensieh M.
    Barghi, Farinaz
    Poursheikhani, Arash
    Dardaei, Leila
    Bashash, Davood
    Ghazi-Khansari, Mahmoud
    Tavangar, Seyyed M.
    Dehpour, Ahmad R.
    Yaghmaie, Marjan
    Alimoghaddam, Kamran
    Ghavamzadeh, Ardeshir
    Ghaffari, Seyed H.
    SCIENTIFIC REPORTS, 2017, 7
  • [17] T cells expressing chimeric PD1 receptors that contain a Dap10 costimulatory domain are a potential treatment for multiple types of cancer
    Deal, Kelsey
    Nylen, Emily
    Barber, Amorette E.
    CANCER RESEARCH, 2017, 77
  • [18] Anti-tumor activity of human T cells expressing the CC49-ζ chimeric immune receptor
    McGuinness, RP
    Ge, Y
    Patel, SD
    Kashmiri, SVS
    Lee, HS
    Hand, PH
    Schlom, J
    Finer, MH
    McArthur, JG
    HUMAN GENE THERAPY, 1999, 10 (02) : 165 - 173
  • [19] RECOMBINANT GROWTH FACTOR RECEPTORS ENHANCE T-CELL PROLIFERATION AND ANTI-TUMOUR ACTIVITY IN A MODEL OF ADOPTIVE T-CELL THERAPY
    Le Brocq, M.
    Katopodi, T.
    Sykorova, M.
    Crookes, H.
    Hurst, N.
    Hawkins, R.
    Kueberuwa, G.
    Bridgeman, J.
    HUMAN GENE THERAPY, 2019, 30 (12) : A20 - A21
  • [20] Chimeric antigen receptor T cell therapy based on stem cell-like memory T cells enhances anti-tumour effects in multiple myeloma
    Liu, Zhaoyun
    Xu, Xintong
    Wang, Yihao
    Cao, Panpan
    Song, Jia
    Ding, Kai
    Liu, Hui
    Fu, Rong
    CLINICAL AND TRANSLATIONAL MEDICINE, 2025, 15 (03):
12345